10:27 AM EST - NeonMind Biosciences Inc. : Announced the appointment of accomplished pharmaceutical executive Robert Tessarolo as its President and Chief Executive Officer. Mr. Tessarolo has 25 years of experience in the pharmaceutical industry. Most recently, he held the position of President and Chief Executive Officer of Mind Medicine (Mindmed) Inc., a psychedelic drug discovery and drug development company now traded on the NEO exchange, from September 2019 to January 2020. Prior, Mr. Tessarolo was President and Chief Executive Officer of Cipher Pharmaceuticals Inc., a diversified specialty pharmaceutical company listed on the Toronto Stock Exchange. His experience includes executive and key leadership roles that span over two decades including commercial and business development experience with obesity, addiction and neurologic assets. NeonMind Biosciences Inc.
shares C.NEON are trading up 1.89 percent at $0.27.
